Stelara Side Effects / Stelara causes drug induced psoriasis / Biologic problems





The interactive transcript could not be loaded.



Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Sep 2, 2013

PEOPLE, PLEASE COMMENT ! ! Biologic drug use is skyrocketing. These compounds are unlike any drug ever produced by man. They are made from living immune cells and permanently alter the immune system. Please watch this video, then do your own homework. The information is out there. This is the story of Tony, a man who with only mild plaque psoriasis, entered a clinical trial for the Johnson & Johnson biologic drug STELARA. After one year, he had to stop the trial because of a weird EKG heart test. But 60 days after stopping the drug, his life changed forever. Please watch this and go to www.helpfortony.org to help. The pharmaceutical industry are using these drugs, first developed only for terminally ill cancer patients, for all auto-immune issues, even mild ones. We know crohn's disease ankylosing spondylitis, IBS, IBD, psoriatic arthritis, rheumatoid arthritis, Ulcerative Colitis are all painful, horrible diseases. But unless it is literally killing you, please do your homework before you use these compounds. They are only effective for 2 or 3 years, but the effects and new auto-immune diseases caused by these biologics are with you forever. The largest threat being that insurance companies force you to take cheaper, older drugs and prove that you cannot tolerate them BEFORE they will pay for the newer drugs. On their site http://www.aetna.com/cpb/medical/data... Aetna states " Enbrel (etanercept), Humira (adalimumab), Remicade (infliximab), Simponi (golimumab) and Stelara (ustekinumab) brands of targeted immune modulators ("least cost brands of targeted immune modulators") are less costly to Aetna. Consequently, because other brands (e.g., Amevive (alefacept), Actemra (tocilizumab), Cimzia (certolizumab), Kineret (anakinra), Orencia (abatacept), Rituxan (rituximab) and Xeljanz (tofacitinib)) of injectables are more costly than these least cost brands of targeted immune modulators, and least cost brands of targeted immune modulators are at least as likely to produce equivalent therapeutic results, no other brands of targeted immune modulator will be considered medically necessary unless the member has a contraindication, intolerance or incomplete response to at least 2 of the least cost brands of targeted immune modulator: Enbrel, Humira, Remicade, Simponi or Stelara, for the same medically necessary indication. If the least costly targeted immune modulator does not have the labeled indication (see appendix), then Aetna considers medically necessary another brand of targeted immune modulator that has the required labeling indication."

also see http://medsfacts.com/study-STELARA-ca...


Thank you and God Bless

The Friends and Family of Tony

  • Category

  • License

    • Standard YouTube License


When autoplay is enabled, a suggested video will automatically play next.

Up next

to add this to Watch Later

Add to

Loading playlists...